08:01 AM EDT, 08/19/2024 (MT Newswires) -- Tonix Pharmaceuticals Holding ( TNXP ) reported a Q2 loss Monday of $19.28 per diluted share, narrowing from a loss of $49.23 a year earlier.

Three analysts polled by Capital IQ expected a loss of $3.27.

Revenue for the quarter ended June 30 was $2.21 million, compared with no revenue a year earlier.

Three analysts surveyed by Capital IQ expected $3.5 million.

Shares of the company rose 26% in recent pre-bell activity Monday.

Price: 0.5641, Change: +0.12, Percent Change: +26.08